LINK: https://bswhealth.webex.com/bswhealth/j.php?MTID=m1c300301b95f059aa896445d34702ae6

OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) Explain the epidemiology of Opioid Use Disorder (OUD), including prevalence, demographic trends and risk factors (2) Identify the common clinical signs and symptoms of OUD (3) Utilize appropriate screening tools to accurately diagnose OUD with established criteria (4) Describe an example of a comprehensive treatment plan for OUD, including pharmacologic, therapeutic and harm reductions approaches.  

FACULTY DISCLOSURE:  Cheryl Hurd, MD, have/has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER DISCLOSURE: Jay Herd, MD and Dipesh Bista, MD, no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Mary Biggers at Mary.Biggers@BSWHealth.org